SlideShare une entreprise Scribd logo
1  sur  2
Télécharger pour lire hors ligne
International Journal of Scientific and Research Publications, Volume 4, Issue 1, January 2014 1
ISSN 2250-3153
Research on ADR in in-patients using Naronji's and who
scale: A basic necessity for better therapeutic outcomes
and rational drug use
CH.PRAGATHI1
, S.MAHESH KUMAR2
, CH.ANAND KUMAR3
, PRAVEEN KUMAR4
Department of pharmacy practice, Smt.Sarojini Ramulamma College of Pharmacy, SVS Hospital
Department of pharmacy practice, Smt. Sarojini Ramulamma College of Pharmacy, SVS Hospital
Department of pharmaceutical science,J.J.T.UNIVERSITY, Ph.D Scholar
Department of pharmacy practice, Smt.Sarojini Ramulamma College of Pharmacy, SVS Hospital
Email:pragathipharmd@gmail.com.
INTRODUCTION: This research aims at enlightens and emphasizing the most prevailing disease conditions
and disorders which are most common in mahabubnagar locality ,were category A(augmented) type ADR are
more followed by type C(continous).
METHODS: A retrospective research study was conducted using Naronji's and WHO standard scales have
been used to categorise the ADR into category A, category B, category C and category D for the given cases.
Epidemological data like age, ADR, and disease condition prevailing in hospitalised patients are noted and
categorised department wise.
RESULTS: In 290 females and 310 males cases high percentage of ortho related medication ADR (10.61%) in
males than in females were reported followed by CV 63cases (10.5%) in arrythmias, MI, CAD in ratio of
1:2.5:1. It is suceeded by gynaecological medicational ADR accounting for 8.6% and goitor 3.8% are found
which is followed by paediatric cases occupying 6.3% in 600case studies. Naronji's and WHO standard scales
have been used to denoted the ADR category.
Based on age CV are more compared to pulmonary, hepatic, ortho, neurologic,GI, circulatory , renal, and
others.
S.no Conditions No. of pediatrics No. of adult No. of geriatrics
1 CV 38 42 1
2 Endocrine 5 49 56
3 Pulmonary 19 8 15
4 Hepatic 5 10 6
5 Ortho 10 28 43
6 Neurologic 57 19 20
7 GI 13 43 37
8 Circulatory 5 9 3
9 Renal 0 8 6
10 Others 8 20 17
International Journal of Scientific and Research Publications, Volume 4, Issue 1, January 2014 2
ISSN 2250-3153
Among all cases the common avoidable ADR are seen in pulmonary,GI, anaphylaxis, neurologial, CV,
haematological and renal, hepatic and others( HTN, skin rashes, urticaria).
CONCLUSION: The statistical data from the research study is useful in different fields of pharmacy like
pharmacovigilence, clinical pharmacy and pharmacoedidemological studies. Taking this into consideration
pharmacovigilence department has taken measure and considerable decrease in ADR's have been noted. All
hospital organisations need a pharmacist team responsible for medical prescription analysis before preparation,
dispensing and administration of drugs to inpatients. This study provides the significance of highly notable
diseases and related disorders along with common ADR in a given area providing statistical data useful in
different pharmacy and medical fields with main aim of improving the quality of life through rational drug use.
REFERENCES:
Brennan TA, leape ll.laird NM .et al.I ncidence of ADE and negligence in hospitalised patients, N Engl J
Med.1991;324;370-376.
Leap LL, Bates DW, Cullen DJ. et al. Systems analysis of ADR JAMA.1995;274:35-43.
Kohn LT, Corrigan GM Donaldson MS, To err is human ;building a safer health system. Institute of medicines,
Washington DC: National Academy Press;1991.

Contenu connexe

Tendances

Use of potentially inappropriate medicines in elderly A prospective study in ...
Use of potentially inappropriate medicines in elderly A prospective study in ...Use of potentially inappropriate medicines in elderly A prospective study in ...
Use of potentially inappropriate medicines in elderly A prospective study in ...
Dr. Hemant Zaveri
 
Identification and Characterization of Drug (3)
Identification and Characterization of Drug (3)Identification and Characterization of Drug (3)
Identification and Characterization of Drug (3)
Alina Amitai ????? ?????
 
PROs and Patient Preference Studies
PROs and Patient Preference StudiesPROs and Patient Preference Studies
PROs and Patient Preference Studies
Sheily Kamra
 
Translational pharmacology
Translational pharmacologyTranslational pharmacology
Translational pharmacology
lbpearce
 

Tendances (20)

Prescription pattern of drugs in pregnancy induced hypertension in a tertiar...
Prescription pattern of drugs in pregnancy induced hypertension  in a tertiar...Prescription pattern of drugs in pregnancy induced hypertension  in a tertiar...
Prescription pattern of drugs in pregnancy induced hypertension in a tertiar...
 
Use of potentially inappropriate medicines in elderly A prospective study in ...
Use of potentially inappropriate medicines in elderly A prospective study in ...Use of potentially inappropriate medicines in elderly A prospective study in ...
Use of potentially inappropriate medicines in elderly A prospective study in ...
 
Identification and Characterization of Drug (3)
Identification and Characterization of Drug (3)Identification and Characterization of Drug (3)
Identification and Characterization of Drug (3)
 
Clinical Trial Phase 3 And 4
Clinical Trial Phase 3 And 4Clinical Trial Phase 3 And 4
Clinical Trial Phase 3 And 4
 
Mine...
Mine...Mine...
Mine...
 
Coronavirus
CoronavirusCoronavirus
Coronavirus
 
Compendious Study On JNC- 7 In a Tertiary Hospital
Compendious Study On JNC- 7 In a Tertiary HospitalCompendious Study On JNC- 7 In a Tertiary Hospital
Compendious Study On JNC- 7 In a Tertiary Hospital
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardi...
 
Characteristics of efficacy evidence supporting approval of supplemental indi...
Characteristics of efficacy evidence supporting approval of supplemental indi...Characteristics of efficacy evidence supporting approval of supplemental indi...
Characteristics of efficacy evidence supporting approval of supplemental indi...
 
Phase 3 protocol
Phase 3 protocolPhase 3 protocol
Phase 3 protocol
 
Should Metformin Be Continued after Hospital Admission in Patients with Coron...
Should Metformin Be Continued after Hospital Admission in Patients with Coron...Should Metformin Be Continued after Hospital Admission in Patients with Coron...
Should Metformin Be Continued after Hospital Admission in Patients with Coron...
 
Ethical practice and rational use
Ethical practice and rational useEthical practice and rational use
Ethical practice and rational use
 
PROs and Patient Preference Studies
PROs and Patient Preference StudiesPROs and Patient Preference Studies
PROs and Patient Preference Studies
 
Perit dial int 2016-li-481-508
Perit dial int 2016-li-481-508Perit dial int 2016-li-481-508
Perit dial int 2016-li-481-508
 
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
Drug Use Evaluation & Drug Utilisation Review (DUE & DUR)
 
13 vol.-4-issue-2-feb-2013-ijpsr-ra-2131-paper-13 (1)
13 vol.-4-issue-2-feb-2013-ijpsr-ra-2131-paper-13 (1)13 vol.-4-issue-2-feb-2013-ijpsr-ra-2131-paper-13 (1)
13 vol.-4-issue-2-feb-2013-ijpsr-ra-2131-paper-13 (1)
 
Translational pharmacology
Translational pharmacologyTranslational pharmacology
Translational pharmacology
 
Translational pharmacology new approach of drug discovery
Translational pharmacology new approach of drug discoveryTranslational pharmacology new approach of drug discovery
Translational pharmacology new approach of drug discovery
 
3.5 p drug list seminar
3.5 p drug list seminar3.5 p drug list seminar
3.5 p drug list seminar
 

Similaire à Research on ADR in in-patients using Naronji's and who scale: A basic necessity for better therapeutic outcomes and rational drug use

Drug formulary INDIA
Drug formulary INDIADrug formulary INDIA
Drug formulary INDIA
Mohammed Yaser Hussain
 
INSPIRE study BMC 2006
INSPIRE study BMC 2006INSPIRE study BMC 2006
INSPIRE study BMC 2006
Sunil Ramkali
 
introductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdfintroductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdf
Ogunsina1
 

Similaire à Research on ADR in in-patients using Naronji's and who scale: A basic necessity for better therapeutic outcomes and rational drug use (20)

A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...
 
PIIS0885392419305792.pdf
PIIS0885392419305792.pdfPIIS0885392419305792.pdf
PIIS0885392419305792.pdf
 
To study the drug utilization pattern and monitoring
To study the drug utilization pattern and monitoringTo study the drug utilization pattern and monitoring
To study the drug utilization pattern and monitoring
 
Adr project
Adr projectAdr project
Adr project
 
Pharmacovigilance: A review
Pharmacovigilance: A reviewPharmacovigilance: A review
Pharmacovigilance: A review
 
Use of cardiovascular triggers
Use of cardiovascular triggersUse of cardiovascular triggers
Use of cardiovascular triggers
 
Patterns Poster
Patterns PosterPatterns Poster
Patterns Poster
 
Pharmacoepidemiology
Pharmacoepidemiology Pharmacoepidemiology
Pharmacoepidemiology
 
Impact of potential inappropriate nsai ds use in chronic pain
Impact of potential inappropriate nsai ds use in chronic painImpact of potential inappropriate nsai ds use in chronic pain
Impact of potential inappropriate nsai ds use in chronic pain
 
Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retros...
Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retros...Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retros...
Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retros...
 
J IAJPS Immanuels
J IAJPS ImmanuelsJ IAJPS Immanuels
J IAJPS Immanuels
 
Good Pharmacovigilance Practices
Good Pharmacovigilance Practices Good Pharmacovigilance Practices
Good Pharmacovigilance Practices
 
Assessment of drug utilization and rational drug use on WHO indication
Assessment of drug utilization and rational drug use on WHO indicationAssessment of drug utilization and rational drug use on WHO indication
Assessment of drug utilization and rational drug use on WHO indication
 
Drug formulary INDIA
Drug formulary INDIADrug formulary INDIA
Drug formulary INDIA
 
Pharmacovigilance: A Review
Pharmacovigilance: A ReviewPharmacovigilance: A Review
Pharmacovigilance: A Review
 
INSPIRE study BMC 2006
INSPIRE study BMC 2006INSPIRE study BMC 2006
INSPIRE study BMC 2006
 
New pattern clinical study
New pattern clinical studyNew pattern clinical study
New pattern clinical study
 
ADVERSE DRUG REACTION | PHARMACY PRACTICE | PDF | SHIVAM DUBEY B PHARMA | PHA...
ADVERSE DRUG REACTION | PHARMACY PRACTICE | PDF | SHIVAM DUBEY B PHARMA | PHA...ADVERSE DRUG REACTION | PHARMACY PRACTICE | PDF | SHIVAM DUBEY B PHARMA | PHA...
ADVERSE DRUG REACTION | PHARMACY PRACTICE | PDF | SHIVAM DUBEY B PHARMA | PHA...
 
Thesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderlyThesis_PhD_Improving medication safety in the elderly
Thesis_PhD_Improving medication safety in the elderly
 
introductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdfintroductiontopharmacoepidemiology-230613144442-c713d639.pdf
introductiontopharmacoepidemiology-230613144442-c713d639.pdf
 

Plus de ANURAG GROUP OF INSTITUTIONS

TRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEMTRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEM
ANURAG GROUP OF INSTITUTIONS
 
DEVELOPMENT AND OPTIMIZATION OF CIPROFLOXACIN HCL HOLLOW MICROSPHERES (MICRO ...
DEVELOPMENT AND OPTIMIZATION OF CIPROFLOXACIN HCL HOLLOW MICROSPHERES (MICRO ...DEVELOPMENT AND OPTIMIZATION OF CIPROFLOXACIN HCL HOLLOW MICROSPHERES (MICRO ...
DEVELOPMENT AND OPTIMIZATION OF CIPROFLOXACIN HCL HOLLOW MICROSPHERES (MICRO ...
ANURAG GROUP OF INSTITUTIONS
 
FORMULATION AND CHARECTERIZATION OF ITRACONAZOLE ETHOSOMAL GEL FOR TOPICAL AP...
FORMULATION AND CHARECTERIZATION OF ITRACONAZOLE ETHOSOMAL GEL FOR TOPICAL AP...FORMULATION AND CHARECTERIZATION OF ITRACONAZOLE ETHOSOMAL GEL FOR TOPICAL AP...
FORMULATION AND CHARECTERIZATION OF ITRACONAZOLE ETHOSOMAL GEL FOR TOPICAL AP...
ANURAG GROUP OF INSTITUTIONS
 
DEVELOPMENT, FORMULATION AND EVALUATION OF SOLIFINACIN SUCCINATE IMMEDIATE RE...
DEVELOPMENT, FORMULATION AND EVALUATION OF SOLIFINACIN SUCCINATE IMMEDIATE RE...DEVELOPMENT, FORMULATION AND EVALUATION OF SOLIFINACIN SUCCINATE IMMEDIATE RE...
DEVELOPMENT, FORMULATION AND EVALUATION OF SOLIFINACIN SUCCINATE IMMEDIATE RE...
ANURAG GROUP OF INSTITUTIONS
 
ETHOSOMES: A NOVEL TRANSDERMAL DRUG DELIVERY SYSTEM
ETHOSOMES: A NOVEL TRANSDERMAL DRUG DELIVERY SYSTEMETHOSOMES: A NOVEL TRANSDERMAL DRUG DELIVERY SYSTEM
ETHOSOMES: A NOVEL TRANSDERMAL DRUG DELIVERY SYSTEM
ANURAG GROUP OF INSTITUTIONS
 
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...
ANURAG GROUP OF INSTITUTIONS
 
FORMULATION AND EVALUATION OF FLOATING- PULSATILE DRUG DELIVERY SYSTEM OF ACE...
FORMULATION AND EVALUATION OF FLOATING- PULSATILE DRUG DELIVERY SYSTEM OF ACE...FORMULATION AND EVALUATION OF FLOATING- PULSATILE DRUG DELIVERY SYSTEM OF ACE...
FORMULATION AND EVALUATION OF FLOATING- PULSATILE DRUG DELIVERY SYSTEM OF ACE...
ANURAG GROUP OF INSTITUTIONS
 
EVALUATION OF ANTI HYPERLIPIDEMIC ACTIVITY OF MEDICINAL PLANT, ARGYREIA NERVO...
EVALUATION OF ANTI HYPERLIPIDEMIC ACTIVITY OF MEDICINAL PLANT, ARGYREIA NERVO...EVALUATION OF ANTI HYPERLIPIDEMIC ACTIVITY OF MEDICINAL PLANT, ARGYREIA NERVO...
EVALUATION OF ANTI HYPERLIPIDEMIC ACTIVITY OF MEDICINAL PLANT, ARGYREIA NERVO...
ANURAG GROUP OF INSTITUTIONS
 
ANTI DIABETIC EFFECT OF ALSTONIA SCHOLARIS LINN BARK IN ALLOXAN INDUCED DIABE...
ANTI DIABETIC EFFECT OF ALSTONIA SCHOLARIS LINN BARK IN ALLOXAN INDUCED DIABE...ANTI DIABETIC EFFECT OF ALSTONIA SCHOLARIS LINN BARK IN ALLOXAN INDUCED DIABE...
ANTI DIABETIC EFFECT OF ALSTONIA SCHOLARIS LINN BARK IN ALLOXAN INDUCED DIABE...
ANURAG GROUP OF INSTITUTIONS
 

Plus de ANURAG GROUP OF INSTITUTIONS (19)

TRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEMTRANSDERMAL DRUG DELIVERY SYSTEM
TRANSDERMAL DRUG DELIVERY SYSTEM
 
DEVELOPMENT AND OPTIMIZATION OF CIPROFLOXACIN HCL HOLLOW MICROSPHERES (MICRO ...
DEVELOPMENT AND OPTIMIZATION OF CIPROFLOXACIN HCL HOLLOW MICROSPHERES (MICRO ...DEVELOPMENT AND OPTIMIZATION OF CIPROFLOXACIN HCL HOLLOW MICROSPHERES (MICRO ...
DEVELOPMENT AND OPTIMIZATION OF CIPROFLOXACIN HCL HOLLOW MICROSPHERES (MICRO ...
 
FORMULATION AND CHARECTERIZATION OF ITRACONAZOLE ETHOSOMAL GEL FOR TOPICAL AP...
FORMULATION AND CHARECTERIZATION OF ITRACONAZOLE ETHOSOMAL GEL FOR TOPICAL AP...FORMULATION AND CHARECTERIZATION OF ITRACONAZOLE ETHOSOMAL GEL FOR TOPICAL AP...
FORMULATION AND CHARECTERIZATION OF ITRACONAZOLE ETHOSOMAL GEL FOR TOPICAL AP...
 
DEVELOPMENT, FORMULATION AND EVALUATION OF SOLIFINACIN SUCCINATE IMMEDIATE RE...
DEVELOPMENT, FORMULATION AND EVALUATION OF SOLIFINACIN SUCCINATE IMMEDIATE RE...DEVELOPMENT, FORMULATION AND EVALUATION OF SOLIFINACIN SUCCINATE IMMEDIATE RE...
DEVELOPMENT, FORMULATION AND EVALUATION OF SOLIFINACIN SUCCINATE IMMEDIATE RE...
 
PHARMACOGNOSTICAL, PHYTOCHEMICAL AND PHARMACOLOGICAL ASPECTS OF THE LEAF OF F...
PHARMACOGNOSTICAL, PHYTOCHEMICAL AND PHARMACOLOGICAL ASPECTS OF THE LEAF OF F...PHARMACOGNOSTICAL, PHYTOCHEMICAL AND PHARMACOLOGICAL ASPECTS OF THE LEAF OF F...
PHARMACOGNOSTICAL, PHYTOCHEMICAL AND PHARMACOLOGICAL ASPECTS OF THE LEAF OF F...
 
ETHOSOMES: A NOVEL TRANSDERMAL DRUG DELIVERY SYSTEM
ETHOSOMES: A NOVEL TRANSDERMAL DRUG DELIVERY SYSTEMETHOSOMES: A NOVEL TRANSDERMAL DRUG DELIVERY SYSTEM
ETHOSOMES: A NOVEL TRANSDERMAL DRUG DELIVERY SYSTEM
 
FORMULATION DEVELOPMENT OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE BILAYERED...
FORMULATION DEVELOPMENT OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE BILAYERED...FORMULATION DEVELOPMENT OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE BILAYERED...
FORMULATION DEVELOPMENT OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE BILAYERED...
 
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...
FORMULATION AND DEVELOPMENT OF GLICLAZIDE MICROSPHERES FOR PHARMACEUTICAL EVA...
 
DEVELOPMENT OF ITRACONAZOLE IMMEDIATE RELEASE PELLETS BY USING HPMC LOADED IN...
DEVELOPMENT OF ITRACONAZOLE IMMEDIATE RELEASE PELLETS BY USING HPMC LOADED IN...DEVELOPMENT OF ITRACONAZOLE IMMEDIATE RELEASE PELLETS BY USING HPMC LOADED IN...
DEVELOPMENT OF ITRACONAZOLE IMMEDIATE RELEASE PELLETS BY USING HPMC LOADED IN...
 
FORMULATION AND EVALUATION OF FLOATING- PULSATILE DRUG DELIVERY SYSTEM OF ACE...
FORMULATION AND EVALUATION OF FLOATING- PULSATILE DRUG DELIVERY SYSTEM OF ACE...FORMULATION AND EVALUATION OF FLOATING- PULSATILE DRUG DELIVERY SYSTEM OF ACE...
FORMULATION AND EVALUATION OF FLOATING- PULSATILE DRUG DELIVERY SYSTEM OF ACE...
 
FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF CARVEDILOL
FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF CARVEDILOLFORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF CARVEDILOL
FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF CARVEDILOL
 
CARVEDILOL MORE THAN MERE A BETA-BLOCKER
CARVEDILOL MORE THAN MERE A BETA-BLOCKERCARVEDILOL MORE THAN MERE A BETA-BLOCKER
CARVEDILOL MORE THAN MERE A BETA-BLOCKER
 
DEVELOPMENT AND VALIDATION OF CAPECITABINE TABLET (PHARMACEUTICAL DOSAGE FORM...
DEVELOPMENT AND VALIDATION OF CAPECITABINE TABLET (PHARMACEUTICAL DOSAGE FORM...DEVELOPMENT AND VALIDATION OF CAPECITABINE TABLET (PHARMACEUTICAL DOSAGE FORM...
DEVELOPMENT AND VALIDATION OF CAPECITABINE TABLET (PHARMACEUTICAL DOSAGE FORM...
 
EVALUATION OF ANTI HYPERLIPIDEMIC ACTIVITY OF MEDICINAL PLANT, ARGYREIA NERVO...
EVALUATION OF ANTI HYPERLIPIDEMIC ACTIVITY OF MEDICINAL PLANT, ARGYREIA NERVO...EVALUATION OF ANTI HYPERLIPIDEMIC ACTIVITY OF MEDICINAL PLANT, ARGYREIA NERVO...
EVALUATION OF ANTI HYPERLIPIDEMIC ACTIVITY OF MEDICINAL PLANT, ARGYREIA NERVO...
 
ANTI DIABETIC EFFECT OF ALSTONIA SCHOLARIS LINN BARK IN ALLOXAN INDUCED DIABE...
ANTI DIABETIC EFFECT OF ALSTONIA SCHOLARIS LINN BARK IN ALLOXAN INDUCED DIABE...ANTI DIABETIC EFFECT OF ALSTONIA SCHOLARIS LINN BARK IN ALLOXAN INDUCED DIABE...
ANTI DIABETIC EFFECT OF ALSTONIA SCHOLARIS LINN BARK IN ALLOXAN INDUCED DIABE...
 
Specific role of excipients in tablet production
Specific role of excipients in tablet productionSpecific role of excipients in tablet production
Specific role of excipients in tablet production
 
Methods used for the manufacture of tablets
Methods used for the manufacture of tabletsMethods used for the manufacture of tablets
Methods used for the manufacture of tablets
 
Pharmacy practice in india
Pharmacy practice in india Pharmacy practice in india
Pharmacy practice in india
 
Pharmacy practice in india
Pharmacy practice in india Pharmacy practice in india
Pharmacy practice in india
 

Dernier

Module for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learningModule for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learning
levieagacer
 
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptxTHE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
ANSARKHAN96
 
Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.
Silpa
 
Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.
Silpa
 
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsBiogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Sérgio Sacani
 
Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptx
MohamedFarag457087
 

Dernier (20)

TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRingsTransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
 
FAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceFAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical Science
 
Site Acceptance Test .
Site Acceptance Test                    .Site Acceptance Test                    .
Site Acceptance Test .
 
Module for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learningModule for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learning
 
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptxTHE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
THE ROLE OF BIOTECHNOLOGY IN THE ECONOMIC UPLIFT.pptx
 
PSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptxPSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptx
 
Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.Phenolics: types, biosynthesis and functions.
Phenolics: types, biosynthesis and functions.
 
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICEPATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
 
Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.
 
Role of AI in seed science Predictive modelling and Beyond.pptx
Role of AI in seed science  Predictive modelling and  Beyond.pptxRole of AI in seed science  Predictive modelling and  Beyond.pptx
Role of AI in seed science Predictive modelling and Beyond.pptx
 
Thyroid Physiology_Dr.E. Muralinath_ Associate Professor
Thyroid Physiology_Dr.E. Muralinath_ Associate ProfessorThyroid Physiology_Dr.E. Muralinath_ Associate Professor
Thyroid Physiology_Dr.E. Muralinath_ Associate Professor
 
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsBiogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
 
Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.Atp synthase , Atp synthase complex 1 to 4.
Atp synthase , Atp synthase complex 1 to 4.
 
Use of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxUse of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptx
 
Genome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptxGenome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptx
 
module for grade 9 for distance learning
module for grade 9 for distance learningmodule for grade 9 for distance learning
module for grade 9 for distance learning
 
GBSN - Microbiology (Unit 3)Defense Mechanism of the body
GBSN - Microbiology (Unit 3)Defense Mechanism of the body GBSN - Microbiology (Unit 3)Defense Mechanism of the body
GBSN - Microbiology (Unit 3)Defense Mechanism of the body
 
Digital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptxDigital Dentistry.Digital Dentistryvv.pptx
Digital Dentistry.Digital Dentistryvv.pptx
 
Factory Acceptance Test( FAT).pptx .
Factory Acceptance Test( FAT).pptx       .Factory Acceptance Test( FAT).pptx       .
Factory Acceptance Test( FAT).pptx .
 
Molecular markers- RFLP, RAPD, AFLP, SNP etc.
Molecular markers- RFLP, RAPD, AFLP, SNP etc.Molecular markers- RFLP, RAPD, AFLP, SNP etc.
Molecular markers- RFLP, RAPD, AFLP, SNP etc.
 

Research on ADR in in-patients using Naronji's and who scale: A basic necessity for better therapeutic outcomes and rational drug use

  • 1. International Journal of Scientific and Research Publications, Volume 4, Issue 1, January 2014 1 ISSN 2250-3153 Research on ADR in in-patients using Naronji's and who scale: A basic necessity for better therapeutic outcomes and rational drug use CH.PRAGATHI1 , S.MAHESH KUMAR2 , CH.ANAND KUMAR3 , PRAVEEN KUMAR4 Department of pharmacy practice, Smt.Sarojini Ramulamma College of Pharmacy, SVS Hospital Department of pharmacy practice, Smt. Sarojini Ramulamma College of Pharmacy, SVS Hospital Department of pharmaceutical science,J.J.T.UNIVERSITY, Ph.D Scholar Department of pharmacy practice, Smt.Sarojini Ramulamma College of Pharmacy, SVS Hospital Email:pragathipharmd@gmail.com. INTRODUCTION: This research aims at enlightens and emphasizing the most prevailing disease conditions and disorders which are most common in mahabubnagar locality ,were category A(augmented) type ADR are more followed by type C(continous). METHODS: A retrospective research study was conducted using Naronji's and WHO standard scales have been used to categorise the ADR into category A, category B, category C and category D for the given cases. Epidemological data like age, ADR, and disease condition prevailing in hospitalised patients are noted and categorised department wise. RESULTS: In 290 females and 310 males cases high percentage of ortho related medication ADR (10.61%) in males than in females were reported followed by CV 63cases (10.5%) in arrythmias, MI, CAD in ratio of 1:2.5:1. It is suceeded by gynaecological medicational ADR accounting for 8.6% and goitor 3.8% are found which is followed by paediatric cases occupying 6.3% in 600case studies. Naronji's and WHO standard scales have been used to denoted the ADR category. Based on age CV are more compared to pulmonary, hepatic, ortho, neurologic,GI, circulatory , renal, and others. S.no Conditions No. of pediatrics No. of adult No. of geriatrics 1 CV 38 42 1 2 Endocrine 5 49 56 3 Pulmonary 19 8 15 4 Hepatic 5 10 6 5 Ortho 10 28 43 6 Neurologic 57 19 20 7 GI 13 43 37 8 Circulatory 5 9 3 9 Renal 0 8 6 10 Others 8 20 17
  • 2. International Journal of Scientific and Research Publications, Volume 4, Issue 1, January 2014 2 ISSN 2250-3153 Among all cases the common avoidable ADR are seen in pulmonary,GI, anaphylaxis, neurologial, CV, haematological and renal, hepatic and others( HTN, skin rashes, urticaria). CONCLUSION: The statistical data from the research study is useful in different fields of pharmacy like pharmacovigilence, clinical pharmacy and pharmacoedidemological studies. Taking this into consideration pharmacovigilence department has taken measure and considerable decrease in ADR's have been noted. All hospital organisations need a pharmacist team responsible for medical prescription analysis before preparation, dispensing and administration of drugs to inpatients. This study provides the significance of highly notable diseases and related disorders along with common ADR in a given area providing statistical data useful in different pharmacy and medical fields with main aim of improving the quality of life through rational drug use. REFERENCES: Brennan TA, leape ll.laird NM .et al.I ncidence of ADE and negligence in hospitalised patients, N Engl J Med.1991;324;370-376. Leap LL, Bates DW, Cullen DJ. et al. Systems analysis of ADR JAMA.1995;274:35-43. Kohn LT, Corrigan GM Donaldson MS, To err is human ;building a safer health system. Institute of medicines, Washington DC: National Academy Press;1991.